Home › Samsung revs up biotech business
 

Keywords :   


Samsung revs up biotech business

2015-02-13 16:20:45| Chemicals - Topix.net

Samsung Group is pouring resources to spur its lackluster biotechnology business as its next growth engine. Samsung BioLogics, the group's pharmaceutical unit, said Thursday it would issue new shares worth 146.1 billion won this month and use the secured cash on plant expansion and ongoing biosimilar projects.

Tags: business samsung biotech revs

Category:Chemicals

Latest from this category

All news
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
04.10RPM General Counsel Edward W. Moore to Retire
04.10AkzoNobel to Review Portfolio with Early Focus on Deco South Asia
03.10AkzoNobel Goes Extra Mile to Help Residents of Worlds Highest Motorable Village
03.10PPG Wins 2024 Supplier Excellence Award from Caterpillar Inc.
02.10RPM Reports Record Fiscal 1Q 2025 Results
02.10Evonik Breaks Ground on Major Silica Expansion at Charleston
01.10BCF CEO Tom Bowtell is Honored for Outstanding Leadership
Chemicals »
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »